Trastuzumab-associated autoimmune thyroid disease in a patient with metastatic breast cancer |
Min, Hong Ki
(Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Kim, In-Ho (Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Kim, Jae Young (Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Ban, Tae-hyun (Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Kim, Kyung Hoon (Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Ha, Jeonghoon (Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Kim, Jung-Hoon (Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) |
1 | Jalalat SZ, Cohen PR. Gefitinib-associated vitiligo: report in a man with parotid squamous cell carcinoma and review of drug-induced hypopigmentation. Dermatol Online J 2013;19:20020. |
2 | Weetman A. Immune reconstitution syndrome and the thyroid. Best Pract Res Clin Endocrinol Metab 2009;23:693-702. DOI |
3 | Pollack BP, Sapkota B, Cartee TV. Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes. Clin Cancer Res 2011;17:4400-4413. DOI |
4 | Brown RS. Autoimmune thyroid disease: unlocking a complex puzzle. Curr Opin Pediatr 2009;21:523-528. DOI |
5 | Grani G, Dicorato P, Dainelli M, et al. Thyroid diseases in women with breast cancer. Clin Ter 2012;163:e401-e404. |
![]() |